A comprehensive understanding of the interplay between lipid metabolism, cholesterol transport, and the oxidative modulation of ABCA1 and ABCG1 transporters thus provides an essential framework for elucidating novel therapeutic strategies aimed at preventing and treating atherosclerosis and related metabolic disorders [28,29]. This evidence concerns the gene ABCA1 and atherosclerosis.